What are PTC Therapeutics's profit margins?

PTC Therapeutics (PTCT) runs a 96.0% gross margin and a 1.6% operating margin, with a 42.3% net margin.

Where do PTC Therapeutics's ratios come from?

Every ratio is computed from PTC Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

PTC Therapeutics PTCT Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	1.6%-38.7pp	54.2%+91.7pp	43.6%+59.2pp	40.7%+63.3pp	40.2%+80.5pp
EBITDA margin	7.3%-34.5pp	56.5%+84.6pp	45.4%+44.4pp	42.3%+42.1pp	41.8%+55.1pp
Efficiency
Asset turnover	0.3×-0.5×	0.8×+0.3×	0.8×+0.2×	0.8×+0.2×	0.8×+0.3×
Liquidity
Current ratio	2.4×-1.5×	2.3×0.0×	2.3×+0.2×	3.6×+1.4×	3.9×+1.9×
Quick ratio	2.4×-1.5×	2.3×0.0×	2.3×+0.2×	3.6×+1.4×	3.9×+1.9×
Cash ratio	0.9×-1.6×	1×-0.3×	0.8×-0.1×	1.6×+0.5×	2.5×+1.5×
Leverage
Debt-to-assets	0.1×0.0×	0.1×-0.1×	0.2×-0.1×	0.1×-0.1×	0.1×-0.1×
Net debt / EBITDA	-7.3×—	-0.6×—	——	——	——
Per Share
Book value per share	-$2.19-1.7%	-$2.32+83.7%	-$1.79+87.0%	-$2.64+79.3%	-$2.15+81.6%
Valuation
Market capitalization	$5.64B+40.3%	$6.1B+75.2%	$4.88B+71.3%	$3.93B+68.1%	$4.02B+83.0%
Enterprise value	$5.2B+77.3%	$5.51B+78.2%	$4.61B+69.4%	$3.31B+58.9%	$2.93B+41.6%
Price / sales	6.8×+4.6×	3.5×-0.8×	2.7×-0.4×	2.2×-0.4×	2.3×-0.1×
EV / EBITDA	86.6×—	5.6×—	——	——	——
EV / sales	6.3×+4.6×	3.2×-0.6×	2.6×-0.4×	1.9×-0.4×	1.7×-0.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about PTC Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are PTC Therapeutics's profit margins?: PTC Therapeutics (PTCT) runs a 96.0% gross margin and a 1.6% operating margin, with a 42.3% net margin.
Where do PTC Therapeutics's ratios come from?: Every ratio is computed from PTC Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.